Skip to main content
Home
NASTAD
  • Resources
  • Member Directory
Request TA
  • Careers
  • Events
  • Donations & Payments
Search the site
Resources

Long-Acting Injectable Cabotegravir Dosing

Last Updated
Jun 15, 2022

This infographic walks through the initiation and dosing schedule for Apretude® to assist HIV prevention programs in implementing long-acting injectable PrEP.

Downloads

Document
Long-Acting Injectable Cabotegravir Dosing Infographic
Related Issues
PrEP and PEP
  • NASTAD
    • Careers
    • Resources
    • Events
  • Membership
    • Request Technical Assistance
    • Member Directory
    • Donations & Payments
  • Connect With Us
    • For press inquiries, email press@NASTAD.org

NASTAD is a CDC-funded Capacity Building Assistance (CBA) Provider

©2025 NASTAD | Privacy Policy | 202.434.8090